Traditional opioid analgesics remain the “gold standard” for managing moderate-to-severe pain. There is an urgent need for advanced pharmacological tools to facilitate the discovery of safer and more effective analgesics. Fluorescent probe technology offers high sensitivity and a favorable signal-to-noise ratio, making it well-suited for visualizing cellular signaling events as well as ligand−receptor interactions both in vitro and in vivo. This perspective provides a systematic overview of advances in fluorescent probes targeting the four opioid receptor subtypes (μ-, κ-, δ-opioid and nociceptin/orphanin FQ receptor), focusing on ligand scaffold and fluorophore designs, imaging applications, and technical advantages. We also discuss current challenges and future directions. Overall, this perspective provides a comprehensive reference for research and applications of opioid receptor fluorescent probes, thereby facilitating their extensive utilization in elucidating opioid analgesic mechanisms and side effects.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: